CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net income (loss)	$ 11,157,000	$ (1,913,000)	$ 13,279,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	5,749,000	6,524,000	6,945,000
Deferred income tax expense (benefit)	195,000	(545,000)	1,420,000
Impairment of intangible assets		5,149,000
Amortization of deferred costs	37,000	40,000	103,000
Compensation expense related to restricted stock awards	1,335,000	2,221,000	2,129,000
(Gain) loss on sale of assets	7,000	(1,247,000)	112,000
(Gain) on insurance claims	(589,000)	(233,000)	(16,000)
Other (gain) losses	(45,000)
Barter (revenue) expense, net	(2,000)	(133,000)	(190,000)
Deferred and other compensation	(215,000)	463,000	(634,000)
Changes in assets and liabilities:
(Increase) decrease in receivables and prepaid expenses	507,000	3,016,000	(5,780,000)
Increase (decrease) in accounts payable, accrued expenses, and other liabilities	968,000	(1,254,000)	7,967,000
Total adjustments	7,947,000	14,001,000	12,056,000
Net cash provided by operating activities	19,104,000	12,088,000	25,335,000
Cash flows from investing activities:
Acquisition of property and equipment	(3,969,000)	(2,314,000)	(5,732,000)
Acquisition of broadcast properties	(150,000)	(190,000)	(763,000)
Proceeds from sale and disposal of assets	142,000	1,691,000	270,000
Proceeds from insurance claims	589,000	233,000
Other investing activities	40,000	(24,000)	(10,000)
Net cash used in investing activities	(3,348,000)	(604,000)	(6,235,000)
Cash flows from financing activities:
Payments on long-term debt	(10,000,000)		(10,000,000)
Cash dividends paid	(1,914,000)	(3,716,000)	(8,623,000)
Purchase of treasury shares	(435,000)	(449,000)	(1,172,000)
Net cash used in financing activities	(12,349,000)	(4,165,000)	(19,795,000)
Net increase (decrease) in cash and cash equivalents	3,407,000	7,319,000	(695,000)
Cash and cash equivalents, beginning of period	51,353,000	44,034,000	44,729,000
Cash and cash equivalents, end of period	$ 54,760,000	$ 51,353,000	$ 44,034,000